| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 7.624 | 52.184 | 53.262 | 55.125 | 77.579 | 81.461 | 68.225 | 61.806 |
| Total Income - EUR | - | - | 7.624 | 52.184 | 53.262 | 55.125 | 77.579 | 81.513 | 68.225 | 62.362 |
| Total Expenses - EUR | - | - | 789 | 7.754 | 7.871 | 8.572 | 14.079 | 19.989 | 15.627 | 15.727 |
| Gross Profit/Loss - EUR | - | - | 6.834 | 44.430 | 45.391 | 46.553 | 63.500 | 61.524 | 52.598 | 46.635 |
| Net Profit/Loss - EUR | - | - | 6.758 | 43.908 | 44.859 | 46.042 | 62.802 | 60.724 | 44.200 | 39.882 |
| Employees | - | - | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Dalvluc Intermed Societate Cu Raspundere Limitată
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 8.449 | 6.402 | 5.614 |
| Current Assets | - | - | 7.268 | 44.547 | 45.717 | 47.244 | 64.016 | 97.946 | 47.652 | 61.745 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 3.674 | 35.550 | 36.031 | 4.917 | 7.625 | 50.816 | 10.389 | 9.317 |
| Cash | - | - | 3.594 | 8.998 | 9.686 | 42.326 | 56.391 | 47.130 | 7.342 | 52.429 |
| Shareholders Funds | - | - | 6.802 | 43.951 | 44.901 | 46.084 | 62.842 | 60.773 | 44.248 | 43.677 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 466 | 596 | 816 | 1.160 | 1.173 | 45.622 | 9.805 | 23.791 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8219 - 8219" | |||||||||
| CAEN Financial Year |
6622
|
|||||||||
Comments - Dalvluc Intermed Societate Cu Raspundere Limitată